Stockholm-based Karo Healthcare says it wants to be a “global commercial force in consumer healthcare.”
Having acquired in recent years various well-known consumer health brands – E45 from Reckitt, Lamisil from Haleon and most recently Proctosedyl from Bayer – Karo is well on its way to achieving this goal, quadrupling its sales in the last five years
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?